Baker Bros. Advisors Lp - Significant Ownership

Signature - Title
/s/ Scott L. Lessing - By: Baker Bros. Advisors (GP) LLC, its general partner Scott L. Lessing/ President
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Baker Bros. Advisors Lp.

Email me when Baker Bros. Advisors Lp files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Baker Bros. Advisors Lp

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PRLD Prelude Therapeutics Inc Common Stock, $0.0001 par value per share 23.5% $8.01M 10.3M Baker Bros. Advisors LP Jun 12, 2025
CELC Celcuity Inc. Common Stock, $0.001 par value per share 18.9% $85.5M $38.5M 7.75M +81.9% Baker Bros. Advisors LP Aug 1, 2025
DBVT DBV Technologies S.A. Ordinary shares, nominal value 0.10 euro per share 17.1% $166M 23.5M Baker Bros. Advisors LP Mar 27, 2025
SERA Sera Prognostics, Inc. Class A Common Stock, $0.0001 par value per share 16.1% $17.9M 5.5M Baker Bros. Advisors LP Feb 12, 2025
REPL Replimune Group, Inc. Common Stock, $0.001 par value per share 14.3% $80.7M 11M Baker Bros. Advisors LP Mar 7, 2025
KALA KALA BIO, Inc. Common Stock, $0.001 par value per share 9.99% $11.4M 745K 0% Baker Bros. Advisors LP Oct 2, 2025
IMTX Immatics N.V. Ordinary Shares, nominal value EUR 0.01 per share 9.95% $103M $16.4M 12.1M +18.9% Baker Bros. Advisors LP Sep 30, 2025
KYMR Kymera Therapeutics, Inc. Common Stock, $0.0001 par value per share 9.5% $214M 6.67M Baker Bros. Advisors LP Jun 26, 2025
RYTM Rhythm Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 8.9% $263M 5.6M Baker Bros. Advisors LP Mar 31, 2025
NGNE Neurogene Inc. Common Stock, par value $0.000001 per share 7% $18.7M -$9.32M 992K -33.3% Julian C. Baker Jun 30, 2025
EWTX Edgewise Therapeutics, Inc. Common Stock, par value $0.0001 per share 6.9% $107M 7.31M Baker Bros. Advisors LP Jun 30, 2025
CERS Cerus Corporation Common Stock, par value $0.001 per share 5.2% $15.9M -$4.57M 10M -22.3% Julian C. Baker Sep 30, 2025
RVMD Revolution Medicines, Inc. Common Stock, par value $0.0001 per share 5% $359M 9.36M Baker Bros. Advisors LP Jun 30, 2025
CADL Candel Therapeutics, Inc. Common Stock, par value $0.01 per share 4.99% $11.7M -$2.51M 2.46M -17.7% Baker Bros. Advisors LP Mar 31, 2025
BMEA Biomea Fusion, Inc. Common Stock, par value $0.0001 per share 4% $2.51M 1.45M Baker Bros. Advisors LP Dec 31, 2024
IGMS IGM Biosciences, Inc. Common Stock, $0.01 par value per share 0% $0 0 Baker Bros. Advisors LP Aug 14, 2025

Schedules 13D/G Reported by Baker Bros. Advisors Lp:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.